Search the Newsreel

ACADIA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director GAROFALO ELIZABETH A. - moomoo

This document is a statement of changes in beneficial ownership of securities for Director Elizabeth A. Garofalo at ACADIA Pharmaceuticals. Such statements are legally required to disclose transactions involving company stock by insiders.

Notice of 2026 Second Quarter Results Conference Call and Webcast for Analysts and Investors

Date:August 6, 2026 Time:1:00 PM (Eastern Time) EDMUNDSTON, New Brunswick, July 17, 2026 (GLOBE NEWSWIRE) -- Acadian Timber Corp. will release its 2026 second quarter results after market close on Wednesday, August 5, 2026, which will be available on our website at www.acadiantimber.com/financial-information/. The …

Academy Sports director Jeffrey C. Tweedy sells 1,200 shares for $57,600

Academy Sports director Jeffrey C. Tweedy sold 1,200 shares of common stock on July 16, 2026, for $48 per share, totaling $57,600. Following the transaction, Tweedy directly held 10,567 shares. The news was generated by AI using information from an SEC filing.

Form 4 Academy Sports Outdoors Inc For: 17 July By Investing.com

This article reports on a Form 4 filing for Academy Sports Outdoors Inc. related to July 17. Form 4 filings disclose changes in ownership of company stock by insiders. The article provides no further details on the specific transactions or individuals involved.

Academy Sports (NASDAQ: ASO) director sells 1200.0000 shares at 48.0000

Academy Sports & Outdoors, Inc. director Jeffrey C. Tweedy sold 1200 shares of common stock at $48.00 per share on July 16, 2026. This open-market transaction was not made under a Rule 10b5-1 trading plan, and after the sale, Tweedy directly holds 10567 shares. …

Understanding the Setup: (ACAD) and Scalable Risk

This article analyzes Acadia Pharmaceuticals Inc. (ACAD) and identifies a potentially high-reward short setup due to conflicting sentiment across different time horizons. It provides distinct AI-generated trading strategies for various risk profiles, including position trading, momentum breakout, and risk hedging strategies, along with multi-timeframe …

Jeff Tweedy plans 1,200-share sale in ASO (NASDAQ: ASO) filing

Jeff Tweedy has filed a Rule 144 notice to sell 1,200 common shares of Academy Sports & Outdoors, Inc. (ASO) through Fidelity Brokerage Services LLC on or after July 16, 2026, with an aggregate value of $57,600. These shares were acquired on June 3, …

Bank of America Securities Sticks to Its Buy Rating for ACADIA Pharmaceuticals (ACAD)

Bank of America Securities analyst Daniel Giraldo reiterated a Buy rating for ACADIA Pharmaceuticals (ACAD) with a price target of $30.00. This follows RBC Capital's maintained Buy rating and $36.00 price target on the stock. ACADIA Pharmaceuticals reported a quarterly revenue of $268.06 million …

Acadia Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 4, 2026

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) announced it will report its second quarter 2026 financial results on Tuesday, August 4, 2026, after the U.S. financial markets close. The company's management team will host a conference call and webcast on the same day at 4:30 p.m. …

Acadia Realty Trust $AKR Shares Sold by Sumitomo Mitsui Trust Group Inc.

Technical Reactions to AKR Trends in Macro Strategies

This article provides a technical analysis of Acadia Realty Trust (NYSE: AKR), highlighting neutral near and mid-term readings that could moderate a long-term positive bias. It identifies an exceptional 18.3:1 risk-reward short setup and outlines three AI-generated trading strategies tailored to different risk profiles. …

Academy Sports+Outdoors nearing opening

Academy Sports+Outdoors is nearing the opening of its new store in Statesboro, Georgia, located in the University Commons Center. Exterior signs have been installed and the company is actively hiring for 50 to 80 positions. This will be the 24th Academy Sports store in …

KeyBanc Keeps Their Buy Rating on Acadia Healthcare (ACHC)

KeyBanc has reiterated its Buy rating on Acadia Healthcare (ACHC) with a price target of $40.00. This follows similar positive ratings from UBS, while Mizuho Securities maintained a Hold rating. Acadia Healthcare recently reported quarterly revenues of $828.8 million and a net profit of …

ACHC Maintained by Keybanc -- Price Target Raised to $40.00

Keybanc has maintained its "Overweight" rating on Acadia Healthcare Co (ACHC) and raised its price target from $30.00 to $40.00. GuruFocus indicates that ACHC is currently undervalued by 37.3% with a GF Value of $48.69, suggesting a potential investment opportunity despite moderate financial strength …

Truist Raises Acadia Realty Trust (AKR) Price Target, Citing Strong Earnings Growth Outlook

Acadia Realty Trust Announces Pricing of Offering of 9,000,000 Common Shares

Acadia Leadership Transition Raises Questions On Reporting Strength And Growth

ACADIA REALTY TRUST SEC 10-Q Report

Academies Australasia Announces Director’s Shareholding Change

Academies Australasia Group Limited (ASX:AKG)

Academies Australasia Group Limited (AKG.AX) valuation measures and financial statistics